Announced Fri, 31 Jul · 22:10 IST
Aarti Drugs announces leadership transition effective Oct 1, 2026
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹423.00
prior close
₹424.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.7-3.0-2.7-3.0-2.4-2.7-2.8-1.1+0.0+2.4-0.1+0.5——
Up moveDown movePending
AI summary
Aarti Drugs announced leadership changes effective Oct 1, 2026. Prakash Patil retires as Chairman, MD and CEO on Sept 30, 2026, ending a tenure since the company inception. Rashesh Gogri, current MD since 2014, is elevated to Chairman in addition to his MD role. Adhish Patil, current CFO since 2014, is appointed as the new MD, subject to shareholder approval at the AGM. Patil senior will continue in an advisory role to support a smooth transition.
Likely market impact
Planned internal succession; long-term strategy unchanged. Watch for AGM approval of the new MD and continuity of growth execution.